Compare OTEX & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTEX | TWST |
|---|---|---|
| Founded | 1991 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.2B |
| IPO Year | 1998 | 2018 |
| Metric | OTEX | TWST |
|---|---|---|
| Price | $24.41 | $119.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 8 |
| Target Price | $36.10 | ★ $46.88 |
| AVG Volume (30 Days) | ★ 1.8M | 1.5M |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.92% | N/A |
| EPS Growth | 56.36 | ★ 63.89 |
| EPS | ★ 2.58 | N/A |
| Revenue | ★ $2,815,241,000.00 | $376,572,000.00 |
| Revenue This Year | $2.82 | $18.91 |
| Revenue Next Year | $1.04 | $15.07 |
| P/E Ratio | $9.64 | ★ N/A |
| Revenue Growth | ★ 22.88 | 20.32 |
| 52 Week Low | $19.78 | $23.30 |
| 52 Week High | $39.90 | $126.40 |
| Indicator | OTEX | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 55.59 | 66.93 |
| Support Level | $21.75 | $84.39 |
| Resistance Level | $25.57 | N/A |
| Average True Range (ATR) | 0.98 | 7.84 |
| MACD | -0.10 | 2.36 |
| Stochastic Oscillator | 49.66 | 90.38 |
Open Text Corp is engaged in the design, development, marketing, and sale of Information Management software and solutions. Its software allows clients to archive, aggregate, retrieve, and search unstructured information (such as documents, e-mail, and presentations). Its platform and services provide secure and scalable solutions for enterprises, SMBs, governments, and consumers around the world. The company's solutions are marketed and delivered on the OpenText Cloud Platform, which is a comprehensive Information Management platform consisting of six business clouds; Content Cloud, Cybersecurity Cloud, Application Automation Cloud, Business Network Cloud, IT Operations Management Cloud, and Analytics Cloud. Geographically, it derives maximum revenue from the United States.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.